Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1
收藏Protein Data Bank Japan2024-11-13 更新2026-03-21 收录
下载链接：
https://pdbj.org/mine/summary/4c4j
下载链接
链接失效反馈官方服务：
资源简介：
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1 Descriptor: DUAL SPECIFICITY PROTEIN KINASE TTK, tert-butyl 6-{[2-chloro-4-(1-methyl-1H-imidazol-5-yl)phenyl]amino}-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate Authors: Naud, S, Westwood, I.M, Faisal, A, Sheldrake, P, Bavetsias, V, Atrash, B, Liu, M, Hayes, A, Schmitt, J, Wood, A, Choi, V, Boxall, K, Mak, G, Gurden, M, Valenti, M, de Haven Brandon, A, Henley, A, Baker, R, McAndrew, C, Matijssen, B, Burke, R, Eccles, S.A, Raynaud, F.I, Linardopoulos, S, van Montfort, R, Blagg, J. Deposit date: 2013-09-05 Release date: 2013-12-04 Last modified: 2024-11-13 Method: X-RAY DIFFRACTION (2.5 Å) Cite: Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3, 2-C]Pyridine Inhibitors of the Mitotic Kinase Monopolar Spindle 1 (Mps1). J.Med.Chem., 56, 2013
创建时间：
2013-09-05
